BOLT logo

Bolt Biotherapeutics (BOLT) Company Overview

Profile

Full Name:

Bolt Biotherapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 5, 2021

Indexes:

Not included

Description:

Bolt Biotherapeutics is a biotechnology company focused on developing innovative cancer therapies. They use a unique approach to harness the immune system to target and destroy cancer cells, aiming to improve treatment outcomes for patients with various types of cancer.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 13, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 HC Wainwright & Co.
Neutral
May 15, 24 Stifel
Hold
May 15, 24 Leerink Partners
Market Perform
May 15, 24 Jones Trading
Hold
May 15, 24 HC Wainwright & Co.
Neutral
May 15, 24 Guggenheim
Neutral
Mar 22, 24 HC Wainwright & Co.
Buy
Aug 8, 23 HC Wainwright & Co.
Buy
Aug 3, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Bolt Biotherapeutics?
  • Does Bolt Biotherapeutics pay dividends?
  • What sector is Bolt Biotherapeutics in?
  • What industry is Bolt Biotherapeutics in?
  • What country is Bolt Biotherapeutics based in?
  • When did Bolt Biotherapeutics go public?
  • Is Bolt Biotherapeutics in the S&P 500?
  • Is Bolt Biotherapeutics in the NASDAQ 100?
  • Is Bolt Biotherapeutics in the Dow Jones?
  • When was Bolt Biotherapeutics's last earnings report?
  • When does Bolt Biotherapeutics report earnings?
  • Should I buy Bolt Biotherapeutics stock now?

What is the ticker symbol for Bolt Biotherapeutics?

The ticker symbol for Bolt Biotherapeutics is NASDAQ:BOLT

Does Bolt Biotherapeutics pay dividends?

No, Bolt Biotherapeutics does not pay dividends

What sector is Bolt Biotherapeutics in?

Bolt Biotherapeutics is in the Healthcare sector

What industry is Bolt Biotherapeutics in?

Bolt Biotherapeutics is in the Biotechnology industry

What country is Bolt Biotherapeutics based in?

Bolt Biotherapeutics is headquartered in United States

When did Bolt Biotherapeutics go public?

Bolt Biotherapeutics's initial public offering (IPO) was on February 5, 2021

Is Bolt Biotherapeutics in the S&P 500?

No, Bolt Biotherapeutics is not included in the S&P 500 index

Is Bolt Biotherapeutics in the NASDAQ 100?

No, Bolt Biotherapeutics is not included in the NASDAQ 100 index

Is Bolt Biotherapeutics in the Dow Jones?

No, Bolt Biotherapeutics is not included in the Dow Jones index

When was Bolt Biotherapeutics's last earnings report?

Bolt Biotherapeutics's most recent earnings report was on Nov 12, 2024

When does Bolt Biotherapeutics report earnings?

The next expected earnings date for Bolt Biotherapeutics is May 14, 2025

Should I buy Bolt Biotherapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions